Nova Biomedical REPL DRIVE BRIDGE CONFIGURED FLEX2 BASIC 62275
Nova Biomedical -- Item TECPIM000412941
Please add to cart & request for quote to see the price
Reserve Now
REPL DRIVE BRIDGE CONFIGURED FLEX2 BASIC 62275 is a specialized component designed for use with Nova Biomedical systems to facilitate fluidic connections and configurations within the analyzer.
Benefits/Advantages:
- Seamless integration with Nova Biomedical analyzers.
- Allows for customized fluidic setups to meet specific testing requirements.
- Enhances operational efficiency and flexibility in testing procedures.
- Reliable performance and durability for long-term use.
Product Details
Overview
| Model | |
|---|---|
| Product Type | Spare Parts |
| Part Number | 62275 |
| Brand | Nova Biomedical |
| Gross Dimensions (WxDxH cm) | |
| Net Dimensions (WxDxH cm) | |
| Gross Weight (kg) | |
| Net Weight (kg) |
Specifications
More options are available. Please contact us for more information.
Document
More options are available. Please contact us for more information.
Videos
Nova Biomedical
Nova Biomedical develops, manufactures, and sells advanced technology blood testing analyzers.
Nova Biomedical is the world technology leader in the development of fast, whole blood analyzers to support the care of hospitalized and critically ill patients. Nova analyzers offer the most extensive stat test menus and deliver results in the shortest time at the lowest costs. Nova also provides handheld meter-and-strip based measuring systems for glucose, ketone, lactate, and creatinine point-of-care testing. Whether testing is performed in the central laboratory or in emergency, surgical, critical, or respiratory care areas, Nova analyzers can help to improve patient outcomes while reducing the cost of care.
With manufacturing facilities in Waltham and Billerica, Massachusetts, Belo Horizonte, Brazil and in Taipei, Taiwan, Nova is one of the 25 largest in vitro diagnostic companies in the world and the largest privately owned in vitro diagnostic company in the United States.